Bodi, V., Sanchis, J., Lopez-Lereu, M. P., Nunez, J., Mainar, L., Monmeneu, J. V., … Llacer, A. (2007). Prognostic Value of Dipyridamole Stress Cardiovascular Magnetic Resonance Imaging in Patients With Known or Suspected Coronary Artery Disease. Journal of the American College of Cardiology, 50(12), 1174-1179. doi:10.1016/j.jacc.2007.06.016
Vincenti, G., Masci, P. G., Monney, P., Rutz, T., Hugelshofer, S., Gaxherri, M., … Schwitter, J. (2017). Stress Perfusion CMR in Patients With Known and Suspected CAD. JACC: Cardiovascular Imaging, 10(5), 526-537. doi:10.1016/j.jcmg.2017.02.006
Bodi, V., Husser, O., Sanchis, J., Núñez, J., Monmeneu, J. V., López-Lereu, M. P., … Llacer, Á. (2012). Prognostic Implications of Dipyridamole Cardiac MR Imaging: A Prospective Multicenter Registry. Radiology, 262(1), 91-100. doi:10.1148/radiol.11110134
[+]
Bodi, V., Sanchis, J., Lopez-Lereu, M. P., Nunez, J., Mainar, L., Monmeneu, J. V., … Llacer, A. (2007). Prognostic Value of Dipyridamole Stress Cardiovascular Magnetic Resonance Imaging in Patients With Known or Suspected Coronary Artery Disease. Journal of the American College of Cardiology, 50(12), 1174-1179. doi:10.1016/j.jacc.2007.06.016
Vincenti, G., Masci, P. G., Monney, P., Rutz, T., Hugelshofer, S., Gaxherri, M., … Schwitter, J. (2017). Stress Perfusion CMR in Patients With Known and Suspected CAD. JACC: Cardiovascular Imaging, 10(5), 526-537. doi:10.1016/j.jcmg.2017.02.006
Bodi, V., Husser, O., Sanchis, J., Núñez, J., Monmeneu, J. V., López-Lereu, M. P., … Llacer, Á. (2012). Prognostic Implications of Dipyridamole Cardiac MR Imaging: A Prospective Multicenter Registry. Radiology, 262(1), 91-100. doi:10.1148/radiol.11110134
Katritsis, D. G., Mark, D. B., & Gersh, B. J. (2018). Revascularization in stable coronary disease: evidence and uncertainties. Nature Reviews Cardiology, 15(7), 408-419. doi:10.1038/s41569-018-0006-z
Kelle, S., Chiribiri, A., Vierecke, J., Egnell, C., Hamdan, A., Jahnke, C., … Gebker, R. (2011). Long-Term Prognostic Value of Dobutamine Stress CMR. JACC: Cardiovascular Imaging, 4(2), 161-172. doi:10.1016/j.jcmg.2010.11.012
Caliendo, M., & Kopeinig, S. (2008). SOME PRACTICAL GUIDANCE FOR THE IMPLEMENTATION OF PROPENSITY SCORE MATCHING. Journal of Economic Surveys, 22(1), 31-72. doi:10.1111/j.1467-6419.2007.00527.x
Timmis, A., Raharja, A., Archbold, R. A., & Mathur, A. (2018). Validity of inducible ischaemia as a surrogate for adverse outcomes in stable coronary artery disease. Heart, 104(21), 1733-1738. doi:10.1136/heartjnl-2018-313230
Hachamovitch, R., Hayes, S. W., Friedman, J. D., Cohen, I., & Berman, D. S. (2003). Comparison of the Short-Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography. Circulation, 107(23), 2900-2907. doi:10.1161/01.cir.0000072790.23090.41
Hachamovitch, R., Rozanski, A., Shaw, L. J., Stone, G. W., Thomson, L. E. J., Friedman, J. D., … Berman, D. S. (2011). Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. European Heart Journal, 32(8), 1012-1024. doi:10.1093/eurheartj/ehq500
2013 ESC guidelines on the management of stable coronary artery disease. (2013). European Heart Journal, 34(38), 2949-3003. doi:10.1093/eurheartj/eht296
Doenst, T., Haverich, A., Serruys, P., Bonow, R. O., Kappetein, P., Falk, V., … Sigusch, H. (2019). PCI and CABG for Treating Stable Coronary Artery Disease. Journal of the American College of Cardiology, 73(8), 964-976. doi:10.1016/j.jacc.2018.11.053
A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. (2009). New England Journal of Medicine, 360(24), 2503-2515. doi:10.1056/nejmoa0805796
Boden, W. E., O’Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., … Weintraub, W. S. (2007). Optimal Medical Therapy with or without PCI for Stable Coronary Disease. New England Journal of Medicine, 356(15), 1503-1516. doi:10.1056/nejmoa070829
Van Nunen, L. X., Zimmermann, F. M., Tonino, P. A. L., Barbato, E., Baumbach, A., Engstrøm, T., … Pijls, N. H. J. (2015). Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. The Lancet, 386(10006), 1853-1860. doi:10.1016/s0140-6736(15)00057-4
De Bruyne, B., Pijls, N. H. J., Kalesan, B., Barbato, E., Tonino, P. A. L., Piroth, Z., … Fearon, W. F. (2012). Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease. New England Journal of Medicine, 367(11), 991-1001. doi:10.1056/nejmoa1205361
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., … Head, S. J. (2018). 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal, 40(2), 87-165. doi:10.1093/eurheartj/ehy394
Al-Lamee, R., Thompson, D., Dehbi, H.-M., Sen, S., Tang, K., Davies, J., … Malik, I. S. (2018). Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. The Lancet, 391(10115), 31-40. doi:10.1016/s0140-6736(17)32714-9
Shaw, L. J., Hausleiter, J., Achenbach, S., Al-Mallah, M., Berman, D. S., Budoff, M. J., … Min, J. K. (2012). Coronary Computed Tomographic Angiography as a Gatekeeper to Invasive Diagnostic and Surgical Procedures. Journal of the American College of Cardiology, 60(20), 2103-2114. doi:10.1016/j.jacc.2012.05.062
Herwig, A., & Weltermann, B. (2017). Study protocol for a matter of heart: a qualitative study of patient factors driving overuse of cardiac catheterisation. BMJ Open, 7(9), e017629. doi:10.1136/bmjopen-2017-017629
Maron, D. J., Hochman, J. S., O’Brien, S. M., Reynolds, H. R., Boden, W. E., Stone, G. W., … Rosenberg, Y. (2018). International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. American Heart Journal, 201, 124-135. doi:10.1016/j.ahj.2018.04.011
[-]